相关实验视频
Updated: May 22, 2025

08:19
Isolation of Leukocytes from the Human Maternal-fetal Interface
Published on: May 21, 2015
16.0K
在怀孕期间发生的淋巴瘤和白血病
Adam S Zayac1, Ogechukwu Egini1, Neil D Palmisiano1
1Division of Blood Disorders, Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Seminars in perinatology
|March 15, 2025
概括
在怀孕期间管理血液性恶性瘤是复杂的,因为密集化疗需要. 本综述提供了诊断和治疗白血病和淋巴瘤等癌症的指导方针,平衡母亲和胎儿的健康.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 妇科瘤学 妇科瘤学
背景情况:
- 怀孕期间的恶性瘤很少见,关于最佳管理策略的数据有限.
- 血液性恶性瘤通常需要多剂细胞毒性化疗,这在怀孕期间与固体瘤相比,带来了独特的挑战.
- 管理这些癌症需要产科医生,孕产妇医学专家和瘤学家之间的密切合作.
研究的目的:
- 审查当前的指导方针和临床经验,用于管理在孕妇患者血液恶性瘤.
- 讨论怀孕期间各种血液癌症的诊断方法和治疗方案.
- 为决策提供指导,权衡不同治疗方式的孕产妇和胎儿风险和益处.
主要方法:
- 审查跨学科专家小组发布的指导方针.
- 综合现有数据和临床经验,管理与怀孕相关的血液性恶性瘤.
- 讨论诊断和治疗策略,包括化疗,细胞疗法,免疫疗法和向药物.
主要成果:
- 怀孕期间的血液恶性瘤需要专门的,多学科的护理.
- 最佳管理需要仔细考虑诊断准确性和治疗疗效.
- 治疗决策必须平衡母亲和胎儿的福祉,利用一系列的治疗选择.
结论:
- 怀孕期间对霍奇金淋巴瘤,非霍奇金淋巴瘤,急性白血病和慢性白血病的有效治疗是可以通过协调护理实现的.
- 指南强调对所有诊断和治疗干预措施进行风险效益分析.
- 持续的研究和数据收集对于完善这些罕见疾病的管理协议至关重要.
相关概念视频
Disorders of Leukocytes
823
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
823
Bone Marrow Sampling and Transplants
269
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
269
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Development of Immunocompetence
280
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
280
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Disorders of the Female Reproductive System
286
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
286

